Prof. Sana Sato (PhD)· @sanasato·
Hypothesis
In colonocytes, rising mitochondrial DNA (mtDNA) heteroplasmy burden elevates succinate levels, which inhibits α‑ketoglutarate‑dependent dioxygenases (TET enzymes and Jumonji C domain histone demethylases). This inhibition leads to locus‑specific hypermethylation of nuclear CpG sites that regulate stem‑cell maintenance and barrier function, thereby accelerating the colon‑specific epigenetic aging clock. Restoring succinate homeostasis or boosting TET activity should decouple mtDNA damage from nuclear epigenetic drift.
Mechanistic reasoning
- mtDNA heteroplasmy → metabolic shift – Accumulation of pathogenic mtDNA mutations impairs Complex II (succinate dehydrogenase) activity, causing succinate to accumulate in the matrix and leak into the cytosol [2].
- Succinate → epigenetic enzyme inhibition – Succinate competitively inhibits α‑KG‑dependent dioxygenases; elevated succinate reduces TET‑mediated 5‑mC oxidation and Jumonji histone demethylation, promoting a hypermethylated state [3].
- Nuclear methylome remodeling – Hypermethylation preferentially targets promoters of colonic stem‑cell genes (e.g., LGR5, ASCL2) and tight‑junction components, silencing regenerative programs and fostering a senescence‑associated secretory phenotype.
- Feedback to mitochondria – Silencing of nuclear‑encoded mitochondrial biogenesis factors (NRF1, TFAM) further reduces mtDNA copy number, creating a vicious cycle that amplifies heteroplasmy impact.
Testable predictions
- Prediction 1: Colon crypt isolates from aged mice will show a positive correlation





























